Hormone shot tested as new weapon against deadly brain cancer
NCT ID NCT05091866
Summary
This early study is testing whether daily progesterone injections can help control tumor growth in adults whose aggressive brain cancer (glioblastoma) has returned. Researchers want to find the safest dose and see if the treatment can stabilize the disease. The study involves a very small group of patients and compares their outcomes to historical data from standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.